Literature DB >> 16936579

Routine duplex ultrasound screening after TKA is not necessary.

Richard Iorio1, Scott Dhupar, William L Healy, Eric Wong.   

Abstract

We determined if negative ultrasound screening at the time of acute care hospital discharge or 2 weeks post operatively would reliably identify patients without deep venous thrombosis, thus allowing discontinuation of warfarin chemoprophylaxis. Patients undergoing primary TKA (1344) were treated with adjusted-dose warfarin (target prothrombin time, 15-18 seconds; internationalized normalization ratio, 1.4-1.7) until screening and then aspirin (325 mg po bid) until 6 weeks postoperatively. Deep venous thrombosis as determined by ultrasound was the measured outcome. From 1994 to 1997, 525 patients underwent screening ultrasound before discharge (usually postoperative Day 3): 12 (2.3%) patients with proximal deep venous thrombosis and three (0.6%) patients with distal deep venous thrombosis were identified. From 1997 to 2001, 819 patients underwent ultrasound screening at Day 14 postoperatively: 10 (1.2%) patients with proximal deep venous thrombosis and 29 (3.6%) patients with distal deep venous thromboses were identified. There was no difference in proximal deep venous thrombosis detection, but there was a difference in distal deep venous thrombosis detection. We no longer screen asymptomatic patients with ultrasound for deep venous thrombosis after TKA.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16936579     DOI: 10.1097/01.blo.0000238804.79788.12

Source DB:  PubMed          Journal:  Clin Orthop Relat Res        ISSN: 0009-921X            Impact factor:   4.176


  2 in total

1.  Duplex Ultrasonography Has Limited Utility in Detection of Postoperative DVT After Primary Total Joint Arthroplasty.

Authors:  Shaleen Vira; Austin J Ramme; Michael J Alaia; David Steiger; Jonathan M Vigdorchik; Frederick Jaffe
Journal:  HSS J       Date:  2016-02-12

2.  High incidence of complications from enoxaparin treatment after arthroplasty.

Authors:  Andrew S Neviaser; Charles Chang; Stephen Lyman; Alejandro Gonzales Della Valle; Steven B Haas
Journal:  Clin Orthop Relat Res       Date:  2009-08-11       Impact factor: 4.176

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.